Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation	Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease	Not yet recruiting	Not applicable	2026-08-25		NCT07784127

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Atmo Biosciences Pty Ltd	1
The Cleveland Clinic	239

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cleveland Clinic	Cleveland	United States	558

Clinical trials